<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5530">
  <stage>Registered</stage>
  <submitdate>6/05/2009</submitdate>
  <approvaldate>6/05/2009</approvaldate>
  <nctid>NCT00894946</nctid>
  <trial_identification>
    <studytitle>The In Vitro Fertilization - Lipiodol Uterine Bathing Effect Study</studytitle>
    <scientifictitle>The in Vitro Fertilisation - Lipiodol Uterine Bathing Effect Study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>IVF-LUBE</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Endometriosis</healthcondition>
    <healthcondition>In Vitro Fertilization Implantation Failure</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Other reproductive health and childbirth disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Menstruation and menopause</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Lipiodol + IVF
Treatment: surgery - IVF

Experimental: Recurrent IVF implantation failure - 

Experimental: Endometriosis - 


Treatment: surgery: Lipiodol + IVF
IVF preceded by lipiodol

Treatment: surgery: IVF
IVF alone

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Live birth</outcome>
      <timepoint>12 months post-randomization</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Clinical pregnancy</outcome>
      <timepoint>3 months post-randomization</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Adverse events</outcome>
      <timepoint>3 &amp; 12 months post-randomization</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  12 or more months infertility

          -  Age 18 to 39

          -  Endometriosis or recurrent IVF implantation failure

          -  Patent fallopian tubes</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>39</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Female</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Iodine allergy

          -  Blocked fallopian tube or tubes</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/05/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>350</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/05/2014</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>University of Auckland, New Zealand</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The hypothesis of this study is that Lipiodol uterine bathing improves the success rate of in
      vitro fertilization (IVF) for women with endometriosis or recurrent IVF implantation failure.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00894946</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Neil Johnson, MD</name>
      <address>University of Auckland, New Zealand</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Neil Johnson, MD</name>
      <address />
      <phone>+64 274360172</phone>
      <fax />
      <email>n.johnson@auckland.ac.nz</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>